Bile Duct Cancer Research from Dana-Farber Cancer Institute
3 Visualizzazioni
• 06/16/23
0
0
Incorporare
administrator
Iscritti
New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti